Hyaluronic acid and endothelial damage due to paracetamol-induced hepatotoxicity

Liver International

Volumn 23, Issue 2, 2003, Pages 110-115

  Williams, Anna M ^a   Langley, Peter G ^a   Osei Hwediah, Johnson ^a   Wendon, Julia A ^a   Hughes, Robin D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Acute liver failure; Hyaluronic acid; Interleukin 8; Paracetamol; Thrombomodulin; von Willebrand factor

Indexed keywords

ACETYLCYSTEINE; HYALURONIC ACID; INTERLEUKIN 8; PARACETAMOL; THROMBOMODULIN; VON WILLEBRAND FACTOR; ANALGESIC AGENT; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL ADMISSION; HUMAN; LIVER SINUSOID; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SURVIVAL; TISSUE INJURY; BLOOD; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; LIVER FAILURE; LIVER TRANSPLANTATION; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; STATISTICS; TIME; TREATMENT OUTCOME; ULTRAFILTRATION; UNITED KINGDOM; VASCULAR ENDOTHELIUM;

ACETAMINOPHEN; ADOLESCENT; ADULT; AGED; ANALGESICS, NON-NARCOTIC; BIOLOGICAL MARKERS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYALURONIC ACID; INTERLEUKIN-8; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; LONDON; MALE; MIDDLE AGED; PATIENT ADMISSION; STATISTICS; SURVIVAL ANALYSIS; THROMBOMODULIN; TIME FACTORS; TREATMENT OUTCOME; ULTRAFILTRATION; VON WILLEBRAND FACTOR;

EID: 0041407282     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2003.00808.x     Document Type: Article

References (22)

1. Fraser J R E, Laurent T C, Laurent U B G. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 1997; 242: 27-33.
2. Tammi R, Agren U M, Tuhkanen A-L, Tammi M. Hyaluronan metabolism in skin. Prog Histochem Cytochem 1994; 29: 1-81.
3. Eriksson S, Fraser J R E, Laurent T C, Pertoft H, Smedsrod B. Endothelial cells are the site of uptake and degradation of hyaluronic acid in the liver. Exp Cell Res 1983; 144: 223-8.
4. Plevris J N, Haydon G H, Simpson K J, et al. Serum hyaluronan - a non-invasive test for diagnosing liver cirrhosis. Eur J Gastroenterol Hepatol 2000; 12: 1121-7.
5. Adams D H, Wang L, Hubscher S C, Neuberger J M. Hepatic endothelial cells. Targets in allograft rejection? Transplantation 1989; 47: 479-82.
6. Bramley P N, Rathbone B J, Forbes M A, Cooper E H, Losowsky M S. Serum hyaluronate as a marker of hepatic derangement in acute liver failure. J Hepatol 1991; 13: 8-13.
7. McKee C M, Penno M B, Cowman M, et al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages - The role of HA size and CD44. J Clin Invest 1996; 98: 2403-13.
8. Blann A D, Taberner D A. A reliable marker of endothelial-cell dysfunction - does it exist? Br J Haematol 1995; 90: 244-8.
9. Baggiolini M, Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett 1992; 307: 97-101.
10. Lee H G, Cowman M K. An agarose gel electrophoretic method for analysis of hyaluronan molecular weight distribution. Anal Biochem 1994; 219: 278-87.
11. Langley P G, Hughes R D, Williams R. Increased factor VIII complex in fulminant hepatic failure. Thromb Haemost 1985; 54: 693-6.
12. O'Grady J, Alexander G J M, Hayllar K M, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-45.
13. Ogata T, Okuda K, Ueno T, Saito N, Aoyagi S. Serum hyaluronan as a predictor of hepatic regeneration after hepatectomy in humans. Eur J Clin Invest 1999; 29: 780-5.
14. Lindqvist U. Is serum hyaluronan a helpful tool in the management of patients with liver disease? J Intern Med 1997; 242: 67-71.
15. Cooper E H, Rathbone B J. Clinical significance of the immunometric measurements of hyaluronic acid. Ann Clin Biochem 1990; 27: 444-51.
16. Suzuki K, Endo R, Onodera M, Iwai M, Takikawa T, Sato S. Serum soluble CD44 levels in patients with acute and fulminant hepatitis. Relationship with serum hyaluronate levels. Hepatol Res 1998; 10: 41-8.
17. Miyamoto S, Eguchi S, Sugiyama N, et al. Hepatic expression and serum levels of thrombomodulin reflect the extent of liver injury in rats with fulminant hepatic failure and extensive hepatectomy. Hepatol Res 2002; 22: 206-13.
18. Rolando N, Harvey F, Brahm J, et al. Prospective study of bacterial infection in acute liver failure: An analysis of fifty patients. Hepatology 1990; 11: 49-53.
19. Matuschak G M, Rinaldo J E. Organ interactions in the adult respiratory distress syndrome during sepsis. Role of the liver in host defence. Chest 1998; 94: 400-6.
20. Berg S. Hyaluronan turnover in relation to infection and sepsis. J Intern Med 1997; 242: 73-7.
21. James S P, Farrar H C, Darville T L, et al. Elevation of serum interleukin-8 levels in acetaminophen overdose in children and adolescents. Clin Pharmacol Ther 2001; 70: 280-6.
22. Hogaboam C M, Bone-Larson C L, Steinhauser M L, et al. Novel CXCR2-dependent liver regenerative qualities of ELR-containing chemokines. FASEB J 1999; 13: 1565-74.